NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
What is the latest Profit Before Tax of NATCO PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹2,291 Cr |
| Mar2024 | ₹1,674 Cr |
| Mar2023 | ₹862 Cr |
| Mar2022 | ₹202 Cr |
| Mar2021 | ₹580 Cr |
How is Profit Before Tax of NATCO PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,291 Cr | 36.92 | |
| Mar2024 | ₹1,674 Cr | 94.16 | |
| Mar2023 | ₹862 Cr | 326.26 | |
| Mar2022 | ₹202 Cr | -65.11 | |
| Mar2021 | ₹580 Cr | - | |
Compare Profit Before Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,713.6 Cr | -20.4% | -14.7% | 15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -20.4% |
-14.7% |
15.6% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses